Not Yet Recruiting OBSERVATIONAL NCT05940363

The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China

Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease With a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies Based on Multi-center Collaboration in China

Sponsor: Beijing Anzhen Hospital

Conditions Congenital Heart Disease in Pregnancy Fetal Echocardiography Prenatal Diagnosis

Interventions Improvement on Prenatal Screening and Treatment Capabilities for Congenital Heart Disease with a Comprehensive Diagnosis and Treatment Program Incorporating New Technologies

Updated 3 times since 2023 Last updated: Jul 2, 2023 Started: Jul 1, 2023 Primary completion: Sep 1, 2023 Completion: Jun 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Congenital Heart Disease in Pregnancy and Fetal Echocardiography and is currently actively recruiting participants. Beijing Anzhen Hospital leads this study, which shows 3 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Aug 2023 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Jul 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.